Skip to main content

Logo (Actavis) 453 Pill - white round, 10mm

Pill with imprint Logo (Actavis) 453 is White, Round and has been identified as Lamotrigine Extended-Release 200 mg. It is supplied by Actavis Pharma, Inc.

Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Logo (Actavis) 453

Lamotrigine extended-release 200 mg Logo (Actavis) 453
Lamotrigine extended-release 200 mg Logo (Actavis) 453 Front
Lamotrigine extended-release 200 mg Logo (Actavis) 453 Back

Lamotrigine Extended-Release

Logo (Actavis) 453
200 mg
10.00 mm
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:2), polyethylene glycol 400, silicon dioxide, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.